BIOLASE, INC Annual Cost of Revenue in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Biolase, Inc quarterly/annual Cost of Revenue history and growth rate from 2010 to 2023.
  • Biolase, Inc Cost of Revenue for the quarter ending September 30, 2024 was $6.47M, a 9.85% decline year-over-year.
  • Biolase, Inc Cost of Revenue for the twelve months ending September 30, 2024 was $30.2M, a 8.36% decline year-over-year.
  • Biolase, Inc annual Cost of Revenue for 2023 was $32.4M, a 0.34% decline from 2022.
  • Biolase, Inc annual Cost of Revenue for 2022 was $32.6M, a 43.7% increase from 2021.
  • Biolase, Inc annual Cost of Revenue for 2021 was $22.7M, a 36.4% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $32.4M -$111K -0.34% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $32.6M +$9.89M +43.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $22.7M +$6.05M +36.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-21
2020 $16.6M -$6.9M -29.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-28
2019 $23.5M -$5.75M -19.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-17
2018 $29.3M -$2.54M -7.99% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-31
2017 $31.8M +$298K +0.95% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-30
2016 $31.5M -$1.02M -3.15% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-08
2015 $32.5M +$3.04M +10.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 $29.5M -$5.42M -15.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-10
2013 $34.9M +$4.02M +13% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-11
2012 $30.9M +$3.34M +12.1% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-06
2011 $27.5M +$10.1M +58.3% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-15
2010 $17.4M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.